Markedly Increased Diamine Oxidase During Acute Anaphylaxis Is Associated With an Underlying Clonal Mast Cell Disorder
Clinical & Experimental Allergy · 2026
DOI: 10.1111/cea.70227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical & Experimental Allergy, 2026. Verfasst von Matija Rijavec und 5 weiteren Autor:innen. Beteiligte Einrichtung: University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia. Hauptthemen laut MEDLINE: Anaphylaxis, Amine Oxidase (Copper-Containing), Mast Cells, Mastocytosis. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovenian Research and Innovation Agency.
Abstract (Originalsprache)
Introduction
Diamine oxidase (DAO) degrades histamine, the key mediator in anaphylaxis, yet its relationship with clonal mast cell disorder (CMD) in the context of anaphylaxis is unclear. We evaluated whether DAO during anaphylaxis differs by CMD status.
Methods
We enrolled 35 emergency‐department patients with acute anaphylaxis to drugs (7 patients), food (2 patients), or Hymenoptera venom (26 patients). Tryptase, DAO, and histamine degradation were measured during anaphylaxis and convalescence. CMD was defined by detecting KIT p.D816V in peripheral blood leukocytes using highly sensitive qPCR. Post‐mortem DAO and tryptase were also compared in two fatal Hymenoptera venom‐triggered anaphylaxis (HVA) cases with CMD versus 13 non‐anaphylaxis controls.
Results
KIT p.D816V was detected in 6 (17%); all had severe HVA and normal basal tryptase. During anaphylaxis, DAO increased markedly in CMD (median 1142%), but only modestly in KIT p.D816V‐negative patients (median 20%; p < 0.0001), independent of trigger or severity. Acute DAO was ~5‐fold higher in CMD (median 101 vs. 18 U/mL), while convalescent DAO was similar (both 14 U/mL). Despite markedly elevated DAO, we observed impaired histamine degradation in acute anaphylaxis plasma. Receiver‐operating‐characteristic analyses showed strong discrimination for CMD using acute DAO (AUC 0.92; cut‐off 53 U/mL; sensitivity 83%; specificity 97%) and percentage increase from convalescence (AUC 0.97; cut‐off 223%; sensitivity 83%; specificity 100%). Post‐mortem DAO lacked specificity, whereas post‐mortem tryptase supported the diagnosis of fatal anaphylaxis and CMD.
Conclusion
DAO concentrations rise markedly during anaphylaxis in CMD and may help identify individuals at the highest risk. Further studies should refine the diagnostic utility and elucidate the mechanisms by which DAO may amplify anaphylaxis in CMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia.
- Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia.
- Faculty of Medicine, University of Maribor, Maribor, Slovenia.
- Institute of Forensic Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
- Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia.
ORCID-Profile: Matija Rijavec, Peter Kopač, Mitja Košnik, Peter Korošec
Förderung
- Slovenian Research and Innovation Agency
Zitieren
APA
Rijavec, M., Kogovšek, Ž., Inkret, J., Kopač, P., Košnik, M., & Korošec, P. (2026). Markedly Increased Diamine Oxidase During Acute Anaphylaxis Is Associated With an Underlying Clonal Mast Cell Disorder. Clinical & Experimental Allergy. https://doi.org/10.1111/cea.70227
Vancouver
Rijavec M, Kogovšek Ž, Inkret J, Kopač P, Košnik M, Korošec P. Markedly Increased Diamine Oxidase During Acute Anaphylaxis Is Associated With an Underlying Clonal Mast Cell Disorder. Clinical & Experimental Allergy. 2026. doi:10.1111/cea.70227
BibTeX
@article{Rijavec2026,
author = {Rijavec, Matija and Kogovšek, Žan and Inkret, Jezerka and Kopač, Peter and Košnik, Mitja and Korošec, Peter},
title = {Markedly Increased Diamine Oxidase During Acute Anaphylaxis Is Associated With an Underlying Clonal Mast Cell Disorder},
journal = {Clinical & Experimental Allergy},
year = {2026},
doi = {10.1111/cea.70227}
}
EUVIMED